MFS Low Volatility Equity R3 holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
MFS Low Volatility Equity Fund Class R3 MLVPX
- NAV / 1-Day Return 18.13 / −0.06 %
- Total Assets 310.4M
-
Adj. Expense Ratio
0.890%
- Expense Ratio 0.890%
- Distribution Fee Level Low
- Share Class Type Retirement, Medium
- Category Large Blend
- Investment Style Large Value
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.79%
- Turnover 23%
USD | NAV as of Jun 06, 2026 | 1-Day Return as of Jun 06, 2026, 2:14 AM GMT+0
Morningstar’s Analysis MLVPX
Will MLVPX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the MLVPX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of MLVPX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 25.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Alphabet Inc Class A | 4.02 | 13M | Communication Services |
Teledyne Technologies Inc | 3.06 | 10M | Technology |
McKesson Corp | 2.80 | 9M | Healthcare |
Johnson & Johnson | 2.78 | 9M | Healthcare |
Apple Inc | 2.47 | 8M | Technology |
Microsoft Corp | 2.23 | 7M | Technology |
Amphenol Corp Class A | 2.20 | 7M | Technology |
NXP Semiconductors NV | 2.10 | 7M | Technology |
Merck & Co Inc | 2.09 | 7M | Healthcare |
Visa Inc Class A | 2.08 | 7M | Financial Services |
United States